Biomarker in Lung Diseases

Feasibility Study on Establishing Biomarkers in Lung Diseases

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00989846

Enrollment

120

Registered

2009-10-06

Start date

2009-10-31

Completion date

2010-06-30

Last updated

2009-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Diseases

Keywords

biomarker, lung disease

Brief summary

Disease related biomarkers have been established decades ago, e.g. blood glucose for diabetes diagnosis and management. Their discovery has grown dramatically during the past decade and they have the potential to lead the physician in diagnosis -especially differential diagnosis - and therapy. However, a specific serum-biomarker in lung diseases has not been established. Aim of the current study is to to measure lung specific proteins in the serum in patients with various lung diseases and to correlate those with disease severity, lung function and other laboratory results

Interventions

OTHERbiomarker

measuring serum-biomarkers

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* age \>= 18 * acute or chronic lung disease

Exclusion criteria

* HIV * lactation or gestation

Design outcomes

Primary

Measure	Time frame
Serum biomarker expression	1 month

Countries

Germany

Contacts

Primary ContactMichael Kreuter, MD

michael.kreuter@thoraxklinik-heidelberg.de49 / 6221 / 396

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026